| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |